Samrat Pharmachem Ltd. benchmarking: Performance to industry peers

Financial

	Samrat Pharmachem	Onyx Biotec	Vineet Laboratories
Operational Metrics
Financials
5 yr Average ROE	18.86 %	13.47 %	6.82 %
5yr average Equity Multiplier	1.83	2.51	4.27
5yr Average Asset Turnover Ratio	2.61	0.82	1.52
5yr Avg Net Profit Margin	3.87 %	6.72 %	-4.28 %
Price to Book	0.98	0.0	4.57
P/E	0.0	0.0	0.0
5yr Avg Cash Conversion Cycle	58.79 Days	36.81 Days	179.8 Days
Inventory Days	28.98 Days	48.71 Days	114.74 Days
Days Receivable	80.32 Days	104.89 Days	109.14 Days
Days Payable	46.76 Days	101.26 Days	115.29 Days
5yr Average Interest Coverage Ratio	16.47	4.89	1.29
5yr Avg ROCE	27.43 %	12.63 %	-1.66 %
5yr Avg Operating Profit Margin	5.58 %	14.14 %	-0.62 %
5 yr average Debt to Equity	0.21	0.95	1.24
5yr CAGR Net Profit	5.93 %	8.12 %	n/a
5yr Average Return on Assets	10.3 %	5.64 %	-2.52 %
Shareholdings
Promoter Holding	49.09 %	65.1 %	5.98 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.45 %	0.0	-32.68 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Samrat Pharmachem	Onyx Biotec	Vineet Laboratories
Product Wise Break-Up	Product Wise Break-Up Dry Powder Syrup 0 Dry Powder Injections 0 Sterile Water Injections 0 Others 100	Product Wise Break-Up Dry Powder Syrup 2.25 Sterile Water Injections 59.49 Dry Powder Injections 38.17 Others 0.09	Product Wise Break-Up Dry Powder Syrup 0 Sterile Water Injections 0 Dry Powder Injections 0 Others 100